
Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. (ARWR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ARWR · as of Jun 8, 2026
Key Statistics
Explore Arrowhead Pharmaceuticals, Inc. Data
arwr stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 20 · Buy rate: 75.0%
The ARWR analyst consensus is Buy, based on ratings from 20 Wall Street analysts over the past 3 months. The average 12-month price target is $83.56, representing +14.32% upside from the current price of $73.09.
Competitors & Peers
arwr competitorsStock Performance
Full HistoryAbout Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therap…
what is arrowhead pharmaceuticals, inc. · arwr stock overview · arrowhead pharmaceuticals, inc. company profile · who is arrowhead pharmaceuticals, inc. ceo · arwr NASDAQ · arrowhead pharmaceuticals, inc. headquarters · arrowhead pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Arrowhead Pharmaceuticals, Inc. (ARWR) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 16, 1993. As of the latest trading session, ARWR stock price is $73.09, with a market capitalization of $10.3B. The stock has returned +341.10% over the past 12 months and +10.09% year-to-date.
According to 20 Wall Street analysts, the consensus rating for Arrowhead Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $83.56. In fiscal year 2025, Arrowhead Pharmaceuticals, Inc. reported revenue of $829.4M and net income of -$1.6M. For detailed data — including Arrowhead Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Arrowhead Pharmaceuticals, Inc. (ARWR) stock price is $73.09. The stock is traded on NASDAQ under the ticker symbol ARWR. The 52-week range is $14.30 – $82.26.